Tuesday, 24 November 2020

Narayana Health joins TriNetX to drive innovation & attract global clinical trials

20 November 2020 | News

Narayana Health (NH) is looking to build on its unique ability to deliver affordable, accessible, evidence-based healthcare at the highest quality standards

Image source: Shutterstock

Image source: Shutterstock

Narayana Health, headquartered in Bengaluru, has joined the TriNetX global health research network to help increase access to data that can drive innovation and expose them to more locally relevant global clinical trials. As a world leader in cardiac care and currently offering a host of other specialties in cancer, vascular sciences, neurological sciences and others, Narayana Health (NH) is looking to build on its unique ability to deliver affordable, accessible, evidence-based healthcare at the highest quality standards.

Narayana Health operates a network of hospitals across India with a particularly strong presence in the southern state of Karnataka and eastern India, as well as an emerging presence in northern, western and central India. Their first facility was established in Bengaluru with approximately 225 operational beds and has since grown to 22 hospitals, 6 heart centers, 19 primary care facilities across India and an international hospital in the Cayman Islands.

"Data drives innovation and continuous innovation brings about change," said Dr. Alben Sigamani, Head Clinical Research at Narayana Health. "Having the ability to transform paper-based data into a digital record that is securely accessible to NH stakeholders will certainly ignite research and innovation. We look forward to greater visibility for our network spread across India and to be recognized as a center of excellence in data-driven healthcare innovation."

TriNetX is the global health research network enabling healthcare organizations (HCOs), biopharmaceutical companies and contract research organizations (CROs) to collaborate, enhance trial design, improve site selection and planning, and bring new therapies to market faster. Each member of TriNetX shares in the consolidated value of its global, federated health research network that connects clinical researchers in real-time to the patient populations which they are attempting to study.

TriNetX offers the fastest growing collaborative research network representing over 170 HCOs and health data partners, spanning 30 countries. TriNetX has presented over 7,800 clinical trial opportunities to its HCO members and has been cited in more than 200 publications.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account